GH Research’s stock rallied after saying the FDA lifted a hold on its experimental depression treatment.
www.marketwatch.com
#small #company #advance #psychedelic #Phase #Heres #matters #psychedelic #biotechs
A small company can now advance its psychedelic into Phase 3. Here’s why that matters to other psychedelic biotechs.
